Skip to main content
. 2022 Jun 10;12(6):869. doi: 10.3390/life12060869
 AMPK  Adenosine Monophosphate Activated Protein Kinase;
 BMI  Body Mass Index;
 CV  Coefficient of Variation;
 CI  Confidence Intervals;
 C16:1  Hexadecenoylcarnitine;
 C14  Tetradecanoylcarnitine;
 C12  Dodecanoylcarnitine;
 C5-OH  Hydroxyvalerylcarnitine;
 C16:2-OH  Hydroxyhexadecadienylcarnitine;
 C3:1  Propenoylcarnitine;
 C2  Acetylcarnitine;
 CPT  Carnitine Palmitoyl-transferase;
 CACT  Carnitine-acylcarnitine Translocase;
 CAT  Carnitine Acyltransferase;
 CoA  Coenzyme A;
 lysoPC 18:2  Lysophosphatidylcholine 18:2;
 LOD  Limit of Detection;
 LC/MC  Long-chain/Medium-chain;
 MRI  Magnetic Resonance Imaging;
 NHANES III  The Third National Health and Nutrition Examination Survey;
 OA  Osteoarthritis;
 PC 44:3  Phosphatidylcholine 44:3;
 PCA  Principal component analysis;
 QC  Quality Control;
 RA  Rheumatoid Arthritis;
 TASOAC  Tasmania Older Adult Cohort;
 TMIC  The Metabolomics Innovation Centre;
 UHPLC  Ultra-high-performance Liquid Chromatography.